4.6 Article

Combined CD4 T-Cell and Antibody Response to Human Minor Histocompatibility Antigen DBY After Allogeneic Stem-Cell Transplantation

Journal

TRANSPLANTATION
Volume 92, Issue 3, Pages 359-365

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3182244cc3

Keywords

Hematopoietic stem-cell transplantation; H-Y antigens; Antibodies; CD4+T cells

Funding

  1. NIH [CA142106, AI29530]

Ask authors/readers for more resources

Background. Antibody responses to HY antigens in male recipients are frequent after transplantation of stem cells from female donors (Miklos et al., Blood 2005; 105: 2973; Miklos et al., Blood 2004; 103: 353). However, evidence that this B-cell immunity is accompanied by T-cell responses to the cognate antigens is scarce. Here, we examined T- and B-cell responses to DBY antigen in a male patient who received hematopoietic stem cells from a human leukocyte antigen-identical female sibling. Materials and Methods. We used 93 overlapping peptides representing the entire DBY protein to detect and characterize T-cell and antibody responses to DBY by enzyme-linked immunosorbent spot (ELISPOT) and enzyme-linked immunosorbent assay. Results. High frequency CD4+ T cells specific for a unique DBY peptide were detected in the patient blood. We isolated the corresponding T-cell clone and characterized the recognized epitope as an 18-mer peptide restricted by human leukocyte antigen-DRB1(star)0101. Upon stimulation, this clone produced cytokines with no evidence of Th1 or Th2 polarization. Remarkably, this clone also recognized the DBX homologue peptide and responded to female donor dendritic cells stimulated with poly I/C or lipopolysaccharide, indicating that the peptide was endogenously processed in these cells. High titer DBY-specific antibodies were also found in the patient serum which, in contrast to the T-cell response, did not cross-react with DBX. Conclusion. We show here the development of a coordinated B and T-cell response to DBY in a recipient of sex mismatched allogeneic hematopoietic stem-cell transplantation. Our findings support a role for CD4+ T cells in the development of humoral immunity to minor histocompatibility antigens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease

Katelyn Paz, Ryan Flynn, Jing Du, Stacey Tannheimer, Amy J. Johnson, Shuai Dong, Anne-Katrien Stark, Klaus Okkenhaug, Angela Panoskaltsis-Mortari, Peter T. Sage, Arlene H. Sharpe, Leo Luznik, Jerome Ritz, Robert J. Soiffer, Corey S. Cutler, John Koreth, Joseph H. Antin, David B. Miklos, Kelli P. MacDonald, Geoffrey R. Hill, Ivan Maillard, Jonathan S. Serody, William J. Murphy, David H. Munn, Colby Feser, Michael Zaiken, Bart Vanhaesebroeck, Aurence A. Turka, John C. Byrd, Bruce R. Blazar

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Article Biophysics

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

Zachariah DeFilipp, Shuli Li, David Avigan, Philippe Armand, Vincent T. Ho, John Koreth, Sarah Nikiforow, Edwin P. Alyea, Jerome Ritz, Vassiliki Boussiotis, Jacalyn Rosenblatt, Jami Brown, Steven McAfee, Bimalangshu R. Dey, Areej El-Jawahri, Thomas R. Spitzer, Yi-Bin Chen, Robert J. Soiffer, Joseph H. Antin, Karen K. Ballen, Corey S. Cutler

BONE MARROW TRANSPLANTATION (2020)

Letter Biophysics

Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation

Theodoros Karantanos, Haesook T. Kim, Natalia M. Tijaro-Ovalle, Lequn Li, Corey Cutler, Joseph H. Antin, Karen K. Ballen, Jerome Ritz, Ioannis Politikos, Vassiliki A. Boussiotis

BONE MARROW TRANSPLANTATION (2020)

Review Hematology

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Nataliya P. Buxbaum, Gerard Socie, Geoffrey R. Hill, Kelli P. A. Macdonald, Victor Tkachev, Takanori Teshima, Stephanie J. Lee, Jerome Ritz, Stefanie Sarantopoulos, Leo Luznik, Defu Zeng, Sophie Paczesny, Paul J. Martin, Steven Z. Pavletic, Kirk R. Schultz, Bruce R. Blazar

Summary: Chronic graft-versus-host disease (cGvHD) remains a significant problem in allogeneic hematopoietic stem cell transplantation. Recent research has provided valuable insights into the pathophysiology of cGvHD, leading to the development of personalized treatment approaches.

BLOOD ADVANCES (2023)

Letter Hematology

Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells

Katie Maurer, Haesook T. Kim, Heather M. Garrity, Deborah Liney, Corey Cutler, Joseph H. Antin, John Koreth, Jerome Ritz, Roman M. Shapiro, Rizwan Romee, Vincent T. Ho, Mahasweta Gooptu, Robert J. Soiffer, Catherine J. Wu, Sarah Nikiforow

BLOOD ADVANCES (2023)

Article Medicine, Research & Experimental

Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity

Alexandre Pellan Cheng, Matthew Pellan Cheng, Wei Gu, Joan Sesing Lenz, Elaine Hsu, Erwin Schurr, Guillaume Bourque, Mathieu Bourgey, Jerome Ritz, Francisco M. Marty, Charles Y. Chiu, Donald C. Vinh, Iwijn De Vlaminck

Summary: The study developed a blood test to quantify cell-, tissue-, and organ-specific injury due to COVID-19, finding evidence of lung and liver injury and involvement of red blood cell progenitors. The concentration of cell-free DNA correlated with disease progression and was significantly increased in patients requiring intubation, suggesting the utility of cell-free DNA as an analyte for monitoring and studying COVID-19.
Meeting Abstract Oncology

Mapping the evolution of T cell states during DLI response and resistance using single-cell data and computational tools

Elham Azizi, Pavan Bachireddy, Vinhkhang N. Nguyen, Shuqiang Li, Donna S. Neuberg, Robert J. Soiffer, Jerome Ritz, Edwin P. Alyea, Dana Pe'er, Catherine J. Wu

CANCER RESEARCH (2019)

Article Hematology

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth

BLOOD ADVANCES (2019)

Article Hematology

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert

BLOOD ADVANCES (2019)

Meeting Abstract Surgery

Galectin-3 Levels Are Associated with the Incidence and Severity of Chronic GVHD One Year after Allogeneic Hematopoietic Cell Transplantation.

N. Navarro-Alvarez, A. R. Andrews, Z. DeFilipp, Y. A. Chen, V. T. Ho, J. Ritz, T. R. Spitzer, C. A. Huang

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Meeting Abstract Biotechnology & Applied Microbiology

Large Scale Manufacturing Process Development for CAR-37 T Cell Therapy using CliniMACS Prodigy System

Alena A. Chekmasova, Irene Scarfo, Helene Negre, Heather Daley, Jack Mai, Shanna Richard, Renee Maxwell, Sarah Nikiforow, Jerome Ritz, Marcela V. Maus

MOLECULAR THERAPY (2019)

Article Hematology

Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease

Roger Belizaire, Haesook T. Kim, Samuel J. Poryanda, Nikola Mirkovic, Evelyn Hipolito, William J. Savage, Carol G. Reynolds, Marie J. Fields, Jennifer Whangbo, Tomohiro Kubo, Sarah Nikiforow, Edwin P. Alyea, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer, John Koreth

BLOOD ADVANCES (2019)

Article Hematology

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease

Jennifer S. Whangbo, Haesook T. Kim, Sarah Nikiforow, John Koreth, Ana C. Alho, Bryn Falahee, Soomin Kim, Katharine Dusenbury, Marie J. Fields, Carol G. Reynolds, Edwin P. Alyea, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz

BLOOD ADVANCES (2019)

Article Immunology

Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease

Maria V. Soares, Rita I. Azevedo, Ines A. Ferreira, Sara Bucar, Ana C. Ribeiro, Ana Vieira, Paulo N. G. Pereira, Ruy M. Ribeiro, Dario Ligeiro, Ana C. Alho, Antonio S. Soares, Nadia Camacho, Carlos Martins, Fernanda Lourenco, Raul Moreno, Jerome Ritz, Joao F. Lacerda

FRONTIERS IN IMMUNOLOGY (2019)

No Data Available